BRIEF published on 04/30/2025 at 12:02, 1 year 4 months ago Arkema Announces Combined Annual General Meeting Details Shareholder Information 2024 Financial Performance Technological Innovations Specialty Materials Arkema Annual Meeting
BRIEF published on 04/30/2025 at 12:02, 1 year 4 months ago Arkema annonce les détails de son assemblée générale mixte Résultats Financiers 2024 Innovations Technologiques Informations Aux Actionnaires Réunion Annuelle D'Arkema Matériaux Spéciaux
PRESS RELEASE published on 04/30/2025 at 11:57, 1 year 4 months ago Inside Information / Other news releases Arkema invites shareholders to its annual general meeting on 22 May 2025. The Group specializes in Specialty Materials and offers innovative solutions in materials science Annual General Meeting Shareholders ARKEMA Specialty Materials Materials Science
PRESS RELEASE published on 04/30/2025 at 11:57, 1 year 4 months ago Informations privilégiées / Autres communiqués Arkema met à disposition des actionnaires les informations relatives à l'Assemblée Générale Mixte du 22 mai 2025. Détails sur site internet. Arkema, leader matériaux spécialisés, présente ses activités innovantes Innovation Informations Assemblée Générale Mixte Matériaux Durables ARKEMA
BRIEF published on 04/29/2025 at 14:24, 1 year 4 months ago BlackRock lowers the 5% threshold of Arkema's capital Voting Rights Capital BlackRock Threshold Crossing ARKEMA
BRIEF published on 04/29/2025 at 14:24, 1 year 4 months ago BlackRock franchit à la baisse le seuil de 5% du capital d'Arkema Capital Droits De Vote Franchissement De Seuil BlackRock ARKEMA
PRESS RELEASE published on 04/29/2025 at 14:19, 1 year 4 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% du capital de la société ARKEMA par BlackRock Inc. pour le compte de clients et de fonds. Détention de 3 746 595 actions représentant 4,93% du capital Déclaration Franchissement De Seuil BlackRock Inc. 5% Du Capital ARKEMA
BRIEF published on 04/29/2025 at 13:56, 1 year 4 months ago Arkema annonce un rachat d'actions le 22 avril 2025 Rachat D'actions Bourse De Paris ARKEMA Règlement De L'UE Avril 2025
BRIEF published on 04/29/2025 at 13:56, 1 year 4 months ago Arkema Announces Share Buyback on April 22, 2025 Share Buyback EU Regulation ARKEMA Paris Stock Exchange April 2025
PRESS RELEASE published on 04/29/2025 at 13:51, 1 year 4 months ago Informations privilégiées / Autres communiqués Arkema annonce avoir réalisé des achats d'actions propres conformément à la réglementation en vigueur. Consultez le site web pour plus d'informations Transactions Réglementation Investisseurs Achats D'actions ARKEMA
Published on 09/11/2026 at 04:00, 8 hours 7 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 42 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 47 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 7 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 24 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 32 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 37 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 1 hour 52 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 7 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 7 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 37 minutes ago Availability of the 2026 Interim Financial Report
